Authors: Bryan Edgar K. Guevara MD, Wei-Ting Tu MD, Ping-Chen Hou, Hsin-Yu Huang MD, Jessica Chen MD, Chao-Kai Hsu MD

Abstract

The new era of molecular diagnostics has provided new insights in both routine clinical work and research in hereditary epidermolysis bullosa (EB). Several different approaches and techniques have provided significant advantages in terms of diagnostic accuracy, predicting prognoses, clarifying the pathogenesis, and developing new therapies. In many developing countries, however, modern laboratory techniques remain inaccessible. Therefore, a practical diagnostic matrix has been developed to predict the diagnosis and subtype of EB. In this review, we highlight the molecular and practical techniques in diagnosing hereditary EB

Citation

Guevara BEK, Tu WT, Hou PC, Huang HY, Chen J, Hsu CK. The practical diagnostic approach for hereditary epidermolysis bullosa in the era of next generation sequencing. J Phil Dermatol Soc 2019, 28(1), 6-9

Figure 1. The patient manifesting with multiple blisters, erosions, and atrophic scars

Keywords

epidermolysis bullosa, molecular genetics, genodermatoses

Fine J-D, Bruckner-Tuderman L, Eady RAJ, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. Journal of the American Academy of Dermatology. 2014;70(6):1103-26.

Lin Z, Li S, Feng C, Yang S, Wang H, Ma D, et al. Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of keratin 14 and human skin fragility. Nature Genetics. 2016;48:1508.

He Y, Maier K, Leppert J, Hausser I, Schwieger-Briel A, Weibel L, et al. Monoallelic mutations in the translation initiation codon of KLHL24 cause skin fragility. American Journal of Human Genetics. 2016;99(6):1395-404.

Lee JYW, Liu L, Hsu C-K, Aristodemou S, Ozoemena L, Ogboli M, et al. Mutations in KLHL24 add to the molecular heterogeneity of epidermolysis bullosa simplex. Journal of Investigative Dermatology. 2017;137(6):1378-80.

Vahidnezhad H, Youssefian L, Saeidian AH, Mahmoudi H, Touati A, Abiri M, et al. Recessive mutation in tetraspanin CD151 causes Kindler syndrome-like epidermolysis bullosa with multi-systemic manifestations including nephropathy. Matrix Biology. 2018;66:22-33.

International Human Genome Sequencing C. Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931.

Grada A, Weinbrecht K. Next-Generation Sequencing: Methodology and Application. Journal of Investigative Dermatology. 2013;133(8):1-4.

Xuan J, Yu Y, Qing T, Guo L, Shi L. Next-generation sequencing in the clinic: promises and challenges. Cancer letters. 2013;340(2):284-95.

Oldfors A, Hedberg-Oldfors C, Visuttijai K, Ahangari N, López MD, Doosti M, et al. Cardiomyopathy with lethal arrhythmias associated with inactivation
of KLHL24. 2019.

Schwieger-Briel A, Fuentes I, Castiglia D, Barbato A, Greutmann M, Leppert J, et al. Epidermolysis Bullosa Simplex with <em>KLHL24</em> Mutations Is Associated with Dilated Cardiomyopathy. Journal of Investigative Dermatology. 2019;139(1):244-9.

Yenamandra VK, van den Akker PC, Lemmink HH, Jan SZ, Diercks GFH, Vermeer M, et al. Cardiomyopathy in patients with epidermolysis bullosa simplex with mutations in KLHL24. British Journal of Dermatology. 2018;179(5):1181-3.

Sterk LMT, Geuijen CAW, van den Berg JG, Claessen N, Weening JJ, Sonnenberg A. Association of the tetraspanin CD151 with the laminin-binding integrins α3β1, α6Β1, α6β4 and α7β1 in cells in culture and in vivo. Journal of Cell Science. 2002;115(6):1161-73.

Yenamandra VK, Moss C, Sreenivas V, Khan M, Sivasubbu S, Sharma VK, et al. Development of a clinical diagnostic matrix for characterizing inherited epidermolysis bullosa. British Journal of Dermatology. 2017;176(6):1624-32.

Rodríguez FA GM, Yubero MJ et al. Novel and recurrent COL7A1 mutations in Chilean patients with dystrophic epidermolysis bullosa. J Dermatol Sci. 2012;65(2):149-52.

Kern JS GG, Imsak R et al. Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort. Br J Dermatol. 2009;161(5):1089-97.

More Articles